| Home | E-Submission | Sitemap | Editorial Office |  
top_img
    
ORIGINAL ARTICLE 2018 February 5
S-1 Based Doublet as an Adjuvant Chemotherapy for Curatively Resected Stage III Gastric Cancer: Results from the Randomized Phase III POST Trial
Purpose We conducted a randomized, multicenter, phase III trial to compare S-1 plus docetaxel (DS) with S-1 plus cisplatin (SP) as adjuvant chemotherapy for stage III gastric cancer patients. Materials and Methods Stage III gastric cancer patients who had received curative ga...
ORIGINAL ARTICLE 2018 February 5
Incremental Role of Pancreatic Magnetic Resonance Imaging after Staging Computed Tomography to Evaluate Patients with Pancreatic Ductal Adenocarcinoma
Purpose The purpose of this study was to investigate the impact of contrast enhanced pancreatic magnetic resonance imaging (MRI) in resectability and prognosis evaluation after staging computed tomography (CT) in patients with pancreatic ductal adenocarcinoma (PDA). Materials ...
ORIGINAL ARTICLE 2018 February 6
The Characteristics and Survival Outcomes in Patients Aged 70 Years and Older with Nasopharyngeal Carcinoma in the Intensity-Modulated Radiotherapy Era
Purpose We aim to examine nasopharyngeal carcinoma (NPC) characteristics and survival outcomes in patients aged 70 years and older in the intensity-modulated radiotherapy (IMRT) era. Methods and Materials From 2006 to 2013, 126 non-metastatic NPC patients aged ≥ 70 years who...
ORIGINAL ARTICLE 2018 February 14
Randomized Open Label Phase III Trial of Irinotecan Plus Capecitabine versus Capecitabine Monotherapy in Patients with Metastatic Breast Cancer Previously Treated with Anthracycline and Taxane: PROCEED Trial (KCSG BR 11-01)
Purpose We investigated whether irinotecan plus capecitabine improved progression-free survival (PFS) compared with capecitabine alone in patients with human epidermal growth factor 2 (HER2) negative and anthracycline and taxane pretreated metastatic breast cancer (MBC). Mate...
Current Issue
Volume 51(1); Jan 2019
Volume 50(4); October 2018
Volume 50(3); July 2018
RSS feed
Blocking Interleukin-4 Receptor α Using Polyethylene Glycol Functionalized Superparamagnetic Iron Oxide Nanocarriers to Inhibit Breast Cancer Cell Proliferation ( 57480 times )
Abjal Pasha Shaik, Asma Sultana Shaik, Ali Al Majwal, Achraf Al Faraj
Cancer Res Treat. 2017;49(2):322-329.   Published online July 12, 2016    DOI: https://doi.org/10.4143/crt.2016.091
                                 Cited By 3
Role of Adjuvant Thoracic Radiation Therapy and Full Dose Chemotherapy in pN2 Non-small Cell Lung Cancer: Elucidation Based on Single Institute Experience ( 36635 times )
Hyojung Park, Dongryul Oh, Yong Chan Ahn, Hongryull Pyo, Jae Myung Noh, Jong-Mu Sun, Jin Seok Ahn, Myung-Ju Ahn, Keunchil Park, Hong Kwan Kim, Yong Soo Choi, Jhingook Kim, Jae Ill Zo, Young Mog Shim
Cancer Res Treat. 2017;49(4):880-889.   Published online December 12, 2016    DOI: https://doi.org/10.4143/crt.2016.442
                              
Risk and Characteristics of Postcolonoscopy Interval Colorectal Cancer after a Positive Fecal Test: A Nationwide Population-Based Study in Korea ( 34302 times )
Chang Kyun Lee, Kui Son Choi, Chang Soo Eun, Dong-Il Park, Dong Soo Han, Minjoo Yoon, Mina Suh, Jae Kwan Jun
Cancer Res Treat. 2018;50(1):50-59.   Published online February 24, 2017    DOI: https://doi.org/10.4143/crt.2017.027
                              Supplementary         Cited By 2
Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2012 ( 29064 times )
Kyu-Won Jung, Young-Joo Won, Hyun-Joo Kong, Chang-Mo Oh, Hyunsoon Cho, Duk Hyoung Lee, Kang Hyun Lee
Cancer Res Treat. 2015;47(2):127-141.   Published online March 3, 2015    DOI: https://doi.org/10.4143/crt.2015.060
                                 Cited By 374
Regulation and Role of EZH2 in Cancer ( 23042 times )
Hirohito Yamaguchi, Mien-Chie Hung
Cancer Res Treat. 2014;46(3):209-222.   Published online July 15, 2014    DOI: https://doi.org/10.4143/crt.2014.46.3.209
                                 Cited By 73
Cancer Statistics in Korea: Incidence, Mortality, Survival and Prevalence in 2010 ( 22878 times )
Kyu-Won Jung, Young-Joo Won, Hyun-Joo Kong, Chang-Mo Oh, Hong Gwan Seo, Jin-Soo Lee
Cancer Res Treat. 2013;45(1):1-14.   Published online March 31, 2013    DOI: https://doi.org/10.4143/crt.2013.45.1.1
                                 Cited By 324
Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2013 ( 22730 times )
Chang-Mo Oh, Young-Joo Won, Kyu-Won Jung, Hyun-Joo Kong, Hyunsoon Cho, Jong-Keun Lee, Duk Hyoung Lee, Kang Hyun Lee, The Community of Population-Based Regional Cancer Registries
Cancer Res Treat. 2016;48(2):436-450.   Published online March 3, 2016    DOI: https://doi.org/10.4143/crt.2016.089
                                 Cited By 187
Conventional Cisplatin-Based Combination Chemotherapy Is Effective in the Treatment of Metastatic Spermatocytic Seminoma with Extensive Rhabdomyosarcomatous Transformation ( 21929 times )
Yumun Jeong, Jaekyung Cheon, Tae-Oh Kim, Doo-Ho Lim, Sunpyo Lee, Young-Mi Cho, Jun Hyuk Hong, Jae Lyun Lee
Cancer Res Treat. 2015;47(4):931-936.   Published online September 11, 2014    DOI: https://doi.org/10.4143/crt.2014.049
                              
The Overexpression of CCAR1 in Hepatocellular Carcinoma Associates with Poor Prognosis ( 21765 times )
Sang Yun Ha, Jeong Hoon Kim, Jung Wook Yang, Jimin Kim, Binnari Kim, Cheol-Keun Park
Cancer Res Treat. 2016;48(3):1065-1073.   Published online October 16, 2015    DOI: https://doi.org/10.4143/crt.2015.302
                                 Cited By 3
Recent Developments in Delivery, Bioavailability, Absorption and Metabolism of Curcumin: the Golden Pigment from Golden Spice ( 21071 times )
Sahdeo Prasad, Amit K. Tyagi, Bharat B. Aggarwal
Cancer Res Treat. 2014;46(1):2-18.   Published online January 15, 2014    DOI: https://doi.org/10.4143/crt.2014.46.1.2
                                 Cited By 243
Korean Cancer Association
E-Submission
EndNote Output Style
Email Alert
Cancer Research and Treatment 2017; 49(4): 915-926.
Impact factor
SCImago Journal & Country Rank
PubMed Central
MEDLINE/PubMed
Scopus
KoreaMed
KoMCI
ScienceCentral
GoogleScholar
Similarity Check
Crossref Cited-by Linking
CrossMark
Funder Registry
ORCID
COPE
Editorial Office
Korean Cancer Association
Room 1824, Gwanghwamun Officia
92 Saemunan-ro, Jongno-gu, Seoul 03186, Korea
TEL: +82-2-3276-2410   FAX: +82-2-792-1410   E-mail: journal@cancer.or.kr
About |  Browse Articles |  Current Issue |  For Authors and Reviewers
Copyright © Korean Cancer Association. All rights reserved.                 Developed in M2Community